Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Enovix Corp Director's Dealing 2021

Jul 17, 2021

31619_dirs_2021-07-16_366ffec6-59f3-49f5-bca8-5322960142dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enovix Corp (ENVX)
CIK: 0001828318
Period of Report: 2021-07-14

Reporting Person: Lahiri Ashok (Chief Technology Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-07-14 Common Stock A 1351031 Acquired 1351031 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-07-14 Stock Option (Right to Buy) $0.0498 A 21538 Acquired 2027-12-13 Common Stock (21538) Direct
2021-07-14 Stock Option (Right to Buy) $9.2626 A 141376 Acquired 2031-04-19 Common Stock (141376) Direct

Footnotes

F1: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.

F2: The shares subject to the option vest in 48 equal monthly installments beginning on the vesting commencement date, September 1, 2017, subject to Reporting Person's continuous service through each such vesting date.

F3: Received in exchange for a stock option to purchase 116,667 shares of Legacy Enovix Common Stock.

F4: The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.

F5: Received in exchange for a stock option to purchase 765,800 shares of Legacy Enovix Common Stock.